← Back to news

Markets

This Dividend ETF You Haven't Heard of Is Springing to Life

Y

Are You Really Ready to Start Collecting Social Security? 3 Signs It Might Be the Perfect Time.

Y

Uber, Mazda Forge New Path To Enhance US Dealership Experience

Y

Forget Tariffs! Earnings Quality Is a Far More Sinister Worry for Wall Street.

Y

Western Digital’s Week in Review: Shares Now Up 63% in 2026

Y

Nio Touts First Adjusted Profit -- Here's What It Isn't Saying

Y

Morgan Stanley Seeks Crypto Talent to Build DeFi and Tokenization Infrastructure

Y

BlackRock & State Street Rejected Her ETF. It Just Returned 5X Its Category Average.

Y

Unlock 7 Hidden Sources of Free Money Most People Forget to Claim

Y

If I Had To Retire With 2 BDCs, These Would Be My Picks

S

Russians spending $648 million on crypto every day, says finance ministry

Y

Turkcell (TKC) 5G Launch in 2026 Seen as Major Growth Catalyst, BofA Retains Buy Rating

Y

Santander (SAN) and Webster Deal Faces Execution Risk, Says Morgan Stanley

Y

ING Groep (ING) Target Raised to €28 on Earnings and Cost Cuts

Y

ArcelorMittal (MT) Reported Strong Q4 2025 Earnings Surprise, Expands Renewable Energy Capacity to 2.8GW by 2028

Y

TotalEnergies (TTE) Expands EV Charging Network in Belgium and Netherlands

Y

Stellantis (STLA) Stock Rated Equalweight by Morgan Stanley After Strategy Concerns

Y

Amcor (AMCR) Delivers Strong EPS and Synergy Gains After Berry Merger, Truist Reiterates Buy

Y

Rio Tinto (RIO) Upgraded to Buy by Erste Group on Copper Growth Outlook

Y

GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17%

Y

Shell (SHEL) Q4 Revenue Beat Estimates, Delivers $43 Billion Operating Cash Flow in 2025

Y

Chubb (CB) Strengthens Emerging Market Growth With Nubank Partnership, Citizens Maintains Market Outperform

Y

3 Smart Tax Moves to Make Before the Midterm Elections

Y

Warren Buffett once said this US investment was ‘terrible long-term.’ Now he has $381 billion of it. Should you get in?

Y

1 Stock to Buy, 1 Stock to Sell This Week: Analog Devices, Walmart

I

Is SCHF the Right International ETF for a Diversified Portfolio?

Y

Charlie Munger once said finfluencers ‘mislead you on purpose’ — here’s the wealth-building plan he recommended instead

Y

Dear Salesforce Stock Fans, Mark Your Calendars for February 25

Y

Analysts are Lovin' McDonald's With Higher Price Targets and Estimates - Is MCD Stock a Buy Here?

Y

Scott Bessent delivers stark message amid massive economic shift, says workers need this skill in 2026 (and beyond)

Y

Georgia financial advisor admitted to scamming $380M from 2,000 clients in Ponzi scheme. How to spot shady investments

Y

What Next For Planet Labs (PL) After Slovenia Partnership?

Y

Is The Negative Analyst Sentiment On Freshworks Inc (FRSH) A Buying Opportunity?

Y

Needham Analysts Stay Bullish On Mobileye Global (MBLY)

Y

RBC Capital Lowers Zeta Global Holdings (ZETA) Price Target to $27

Y

Klaviyo (KVYO) Reports Impressive Earnings But Jeffries Downgrades Target Price To $29

Y

Analysts Are Bullish On Charles River Laboratories (CRL) Prospects

Y

Analyst Upgrade Followed GDS Holdings (GDS) Convertible Notes Offering

Y

Here’s Why UBS Analysts Lowered Monday.com’s (MNDY) Price Target to $93

Y

Strategic Partnership And Strong Earnings Boost Maplebear (CART) Stock

Y

A Housing ETF Up 15.7% Despite 38% Plunge in Key Residential Demand Factor

Y

Capital Southwest: I Went To Dallas For This Safe 11% Dividend Yield Paid Monthly

S

How Trump’s Tariffs and Trade Policy Impact Retirement Portfolios

Y

What Is 1 of the Best Cryptocurrencies to Own for the Next 10 Years?

Y

How Watching Too Much News Could Impact Your Retirement Plans, According to Experts

Y

Binance XRP Reserves Drop to 2024 Lows as Traders Eye Accumulation Signal

Y

Altria Could Shatter Its 52-Week High: This Dividend King Beckons With a 6.4% Yield

Y

Broadcom’s Week in Review: Cathie Wood’s ARK Invests

Y

B.Riley Maintains Buy Rating on Bitmine (BMNR) After Strategic MrBeast Partnership

Y

UBS Reaffirmed Buy Rating on Veracyte (VCYT) After Strong Q4 Testing Revenue

Y